Agenda Setting and Normative Guidance
|
Establishing Research and Development Priorities: Identifying the greatest need for novel approaches, tools, and regimens to improve care |
|
|
Policy and Guideline Development: Synthesizing latest evidence, identifying priority interventions, establishing reference standards and benchmarks |
-
➢
2010 WHO Rapid Advice: Treatment of TB in Children; 2014 Guidance for national TB programs on the management of TB in children
-
✓
2017 WHO Guidelines for the treatment of drug-susceptible TB and patient care establishes person-centered care as a priority for NTPs
-
✓
CaP-TB and DETECT projects inform 2022 WHO child and adolescent TB guidelines
|
|
Establishing Implementation Priorities: Establishing program priorities for implementation |
National TB Strategic Plans and budgets
Global Fund to Fight AIDS, TB and Malaria (GFATM) prioritizes children under 5 for TB funding proposals (2020)
-
➢
NTPs work with the WHO, STP Global Drug Facility (GDF), TB Alliance to prioritize child-friendly FDCs
-
➢
Unitaid and donor organizations from several nations catalyze creation of STEP-TB
-
✓
Uganda NTLP incorporated decentralized care into successive National Strategic Plans (2015–2025) and funding proposals to GFATM
|
Include child and adolescent TB interventions in NSP, costed budgets, and funding proposals
Donors prioritize child and adolescent TB in requests for proposals
|
Operational and Implementation Guidance: Developing tools, algorithms, job aids, training materials, and other practical guidance required for implementation |
The WHO operational handbook accompanying guidelines
STP Child and Adolescent TB Working Group (CAWG) develop budgeting tools to improve costing of child and adolescent TB interventions
WHO releases Best practices in child and adolescent tuberculosis care (2018)
Implementation guidance for use of non-sputum specimens for diagnosis of TB among children
-
➢
The WHO releases Technical Briefing Note: Technical step process to switch to new pediatric TB formulations; TB Alliance and others offer technical support for regulatory and training needs
-
✓
Uganda NTLP adapts approach, training, and tools for expanded scale up beyond pilot districts
|
|
Innovation Inception and Delivery
|
Pre-Clinical Development and Clinical Trials: Trials establishing safety, efficacy, non-inferiority of novel treatment regimens or diagnostic techniques |
TAG Pipeline Report
TB Alliance: New Pathways for Childhood TB Treatment
Clinical trial networks (e.g., IMPAACT4TB, TBTC, DOLPHIN KIDS)
|
|
Regulatory Approval: International and national |
|
|
Market Shaping and Consolidated Procurement: Quantifying market for therapeutics, diagnostics, commodities; consolidated procurement with negotiated prices |
STP/Global Drug Facility
WHO PADO
|
Expand pooled procurement
Incentivize manufacturers of pediatric TB medications through improved stakeholder coordination
Streamline regulatory approvals
Increase consumer education on guidelines
|
Program Implementation and Continuous Quality Improvement
|
Surveillance and Data for Decision Making: Routine recording and reporting of indicators paired with routine use of data and experience to improve performance by targeting gaps and developing solutions |
Making sense of TB data (Zimbabwe)
TB Situation Room (Zambia)
Clinic-Lab Interface for Continuous Quality Improvement (CDC CLICQ!)
-
➢
NTP and TB Alliance monitor proportion of patients receiving new FDC in early rollout; adverse event and discontinuation monitored over time
-
✓
Uganda NTLP monitored expansion of decentralized care approach through routine surveillance in 10 expansion districts
|
|
Training TB Program Staff and Health Care Workers: Providing routine training to all health cadres and volunteers involved in delivery of health services |
-
➢
Health care workers and caregivers trained on administration of new FDC
-
✓
Catalyzing Innovations for Pediatric TB (CaP-TB) and Decentralize TB services and Engage Communities to Transform lives of Children with TB (DETECT TB) projects emphasize training at the primary care level
|
|
Supportive Supervision and Mentorship: Providing oversight against performance targets and mentorship for skill development |
|
|
Operational Research and Program Adaptation: Adapting evidence-based innovations to a specific context through implementation and evaluation |
-
➢
Louder than TB Campaign in Kenya adapts the use of formulation to Kenyan context; IEC materials developed for community
-
➢
Evaluation of FDC palatability and patient preference within SHINE trial documents room for improvement
-
✓
Both Cap-TB and DETECT projects were pilots to adapt recommended approaches to different contexts for the purpose of enabling sustainable scale up
|
|
Communities of Practice (COP): Platforms for sharing best practices and lessons learned in implementation among peers; may provide expert consultation for donor and multilateral institutions |
-
➢
TB Alliance developed a platform for sharing information, lessons learned, and other updates with NTP and program staff in interested countries
-
✓
CaP-TB shares best practices across platform of engaged countries
|
Develop framework for joint responsibility across COPs for agreed-upon priorities
Develop training materials on child and adolescent TB aligned with guidelines and the WHO TB knowledge-sharing platform
|
Platforms for Building Political Will
|
Civil Society and Community Engagement: Raising awareness among general and affected populations, providing input into service delivery and program priorities, and providing support to affected communities |
WHO Civil Society Taskforce
WHO ENGAGE-TB Approach: Operational Guidance
STP Challenge Facility for Civil Society (CFCS)
Global Coalition of TB Activists
|
|
Building Political Will: Raising awareness of the burden of TB among political, opinion, and thought leaders to build political will and investment |
WHO End TB Strategy
UNHLM Political Declaration and 2020 UN Secretary-General progress report
Annual WHO Global Tuberculosis Reports
Global TB Caucus
Rome Action Plan on Pediatric HIV and TB
Dedicated funding for TB prevention and care, from major donors such as the Bill and Melinda Gates Foundation, CDC, the Global Fund, Unitaid and the United States Agency for International Development (USAID) as well as bilateral donors, philanthropists and others
|
|